Dr. med.
Raquel Taddei, PhD
Dr. med. Raquel Taddei, PhD, is a board-certified neurologist (FMH) and Director of the Center for Memory Disorders and Alzheimer’s Disease. She completed her neurology training at the University Hospital Zurich, Inselspital Bern, and the Geneva University Hospitals (HUG). She then pursued a Clinical Fellowship in Movement Disorders at King’s College London before moving to the United States.
In the U.S., she first served as a Clinical Fellow in Dementia at Harvard University and was subsequently appointed Instructor in Neurology at both Harvard University and Yale University. During her time at Harvard (2020–2024), she successfully completed a PhD at University College London.
Dr. Raquel Taddei brings extensive clinical experience in the treatment of neurodegenerative and dementia disorders, particularly in the use of newly approved monoclonal antibodies in Europe, as well as in the management of movement disorders.
December 2025 – Present
Director, Center for Memory Disorders and Alzheimer’s Disease
June 2025 – December 2025
Co-Director, Center for Memory Disorders and Alzheimer’s Disease
October 2024 – June 2025
Lecturer in Neurology, Yale University, USA
September 2022 – August 2024
Lecturer and Clinical Fellow in Dementia, Massachusetts General Hospital (MGH), Harvard Medical School, USA
May 2021 – April 2024
PhD Candidate in Neuroscience, University College London, United Kingdom
July 2020 – August 2022
Research Fellow in Dementia, Harvard Medical School, USA
April 2019 – March 2020
Resident in Neurology, Inselspital Bern, Switzerland
April 2018 – March 2019
Resident in Internal Medicine, Geneva University Hospitals (HUG), Switzerland
October 2016 – March 2018
Clinical Fellow in Movement Disorders, King’s College Hospital, London, United Kingdom
July 2015 – June 2016
Clinical Fellow in Epilepsy, University Hospital Zurich, Switzerland
October 2013 – September 2016
Resident in Neurology, University Hospital Zurich, Switzerland
German
Spanish
English
French